RxDoctor Payments Data

Rachel Mackmin, PA

Medical · Clinton Township, MINPI 1760018808

Payments from drug & device makers

$4,514in general payments, 2019–2025

Across 257 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$901
  • E.r. Squibb & Sons, L.L.C.$499
  • Johnson & Johnson$386
  • Novartis$360
  • AstraZeneca$338
  • Pfizer$304
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,500100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,514 in reported general payments places this provider in the 85th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Medicare billing

Part B allowed, 2024
$45,518
Medicare patients
168
Services billed
551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban164$169,347
Repatha SureclickEvolocumab81$58,072
JardianceEmpagliflozin32$42,730
XareltoRivaroxaban22$22,135
Clonidine18$3,053
Atorvastatin Calcium220$2,832
Metoprolol Succinate156$2,611
Eplerenone19$2,402
Ezetimibe117$2,268
Nifedipine ErNifedipine49$1,453
Losartan Potassium99$1,319
Rosuvastatin Calcium57$1,102
Amiodarone Hcl46$1,086
Potassium Chloride52$906
ClopidogrelClopidogrel Bisulfate35$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$304$169,347164 claims
Boehringer IngelheimJardiance$145$42,73032 claims
Johnson & JohnsonXarelto$386$22,13522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 755 medical providers in Michigan.

Other medical in Clinton Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →